Raritan Pharmaceuticals

Prolong Pharmaceuticals, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for central nervous system, hematology, and respiratory disorders. With a focus on addressing complex diseases like ischemia, hypoxia, stroke, sickle cell disease, and cystic fibrosis, the company leverages its proprietary PEGylation technology to enhance drug delivery and efficacy. The lead product, PP-007 Sanguinate, is designed to restore physiological balance by delivering oxygen to hypoxic tissues and improving perfusion while reducing inflammation. Prolong Pharmaceuticals aims to meet critical unmet medical needs and revolutionize treatment options for severe and life-threatening conditions through its cutting-edge research and development initiatives. Generated from the website

AscellaHealth is a global partner to life sciences and healthcare companies, specializing in end-to-end solutions that enhance innovation and improve the quality of life for patients with complex chronic conditions. The company collaborates with specialty pharmaceutical manufacturers to facilitate the commercialization of therapies designed specifically for these challenges. In addition to their focus on life sciences, AscellaHealth offers tailored pharmacy management solutions for regional health plans and at-risk providers, aiming to effectively manage pharmacy costs. Their resources include a comprehensive library of educational materials, white papers, and engaging podcast episodes that provide insights into the latest trends and challenges in healthcare. Generated from the website

GlobePharma, Inc. is a worldwide company serving the pharmaceutical, food, nutraceutical, automotive & cosmetic industries with solid-dosage form equipment from lab to pilot scale.High-Quality Pharmaceutical Equipment Supplier